Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Lyn Benson who wrote (25598)	9/21/1998 8:54:00 PM
From: Henry Niman	Respond to of 32384

Lyn, I'm trying to get exact dates, but I think that the sequence is Bear Stearns this week (I think that the conference began today and goes through Wednesday), followed by Oppenheimer, Robertson Stephens, and H&Q. I don't think that I will be able to get content, but two years ago, LGND announced the initial preclinical Targretin data for breast cancer and diabetes (see post #0 on this thread).